Idxg stock.
You can watch IDXG and buy or sell other stocks, options, and ETFs commission-free! You can watch IDXG and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Interpace Biosciences against related stocks people have also ...
Gorman Robert J. - PDII / PDI, Inc. - Insider Trade ReportThe stock price for . Interpace Biosciences (OTCQX: IDXG) is $1.08 last updated November 14, 2023 at 12:47 PM UTC. Q Does Interpace Biosciences (IDXG) pay a dividend?Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...The estimated Net Worth of Thomas W. Burnell is at least $437 Mille dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $11,723 and over the last 2 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres e CEO & Director at Interpace Biosciences Inc.James has made over 1 trades of the Interpace Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently James exercised 5,000 units of IDXG stock worth $5,750 on 29 July 2020. The largest trade James's ever made was exercising 5,000 units of Interpace Biosciences Inc stock on 29 July 2020 worth over $5,750.
Joseph D Keegan - IDXG / Interpace Diagnostics Group, Inc. - Insider Trade Report ... (Stocks) Options Flow - Last 7 Days (ETF) Gamma Squeeze; Gamma Pockets; Put/Call Ratio - Top Bullish; Put Call Ratio - Top Bearish; SEC FILINGS SEC Forms Latest S1 (IPO) Filings Latest 13D/G Filings Latest 13F Filings. SCREENER
Nov 8, 2023 · PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended ... Find the latest Research Frontiers Incorporated (REFR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.It was because of IDXG stock I had 2021 which moved to OTC 2021 February 25. I got an alert on TD some time in March or April 3021 and within couple of days I sold it on April 5th. ... When I searched it is Tax payable on non-qualified income. The stock I have is FKWL. It is traded in nasdaq. So I don't know how is that non qualified investment ...Interpace Diagnostics Stock Earnings. The value each IDXG share was expected to gain vs. the value that each IDXG share actually gained. Interpace Diagnostics ( IDXG) reported Q3 2022 earnings per share (EPS) of -$3.35, missing estimates of -$0.25 by 1,239.76%. In the same quarter last year, Interpace Diagnostics 's earnings per share (EPS) was ...The estimated Net Worth of Thomas W. Burnell is at least $435 Thousand dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $10,204 and over the last 3 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres and CEO & Director at Interpace Biosciences Inc.Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations PR Newswire PARSIPPANY, N.J.,
James has made over 1 trades of the Interpace Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently James exercised 5,000 units of IDXG stock worth $5,750 on 29 July 2020. The largest trade James's ever made was exercising 5,000 units of Interpace Biosciences Inc stock on 29 July 2020 worth over $5,750.
EPS is the net income, or profit, a company generates during a period for each share of common stock it has outstanding. Zacks News for IDXG TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue ...
Nov 30, 2023 · Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.13. On a fall, the stock will find some support from the long-term average at approximately $0.99. ٦ جمادى الآخرة ١٤٣٩ هـ ... IDXG signed a new national contract with Aetna for its ThyGenX ... to a particular stock represents solely the analyst's view of how that stock ...Oct 16, 2023 · Interpace Biosciences GAAP EPS of -$0.53, revenue of $10.38M. SA NewsMon, May 16, 2022 1 Comment. After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data ... IDXG is the ticker symbol for Interpace Biosciences, Inc., a company that provides molecular diagnostic tests for cancer and other diseases. The stock price, news, quote and history of IDXG are shown on Yahoo Finance, as well as its performance outlook, earnings, dividends and research reports.Suneet Singal announces successful $350M real estate acquisition by FTE Networks Inc. & $100M Stock Distribution to the common shareholders of First Capital Real Estate Trust Inc. November 11, 2019 | www.msn.com. BRIEF-FTE Networks Reports Extension Of Indebtedness And Continuing Negotiations For Possible Business Combination.
PARSIPPANY, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fiscal quarter ended March 31, 2021 and provided a business and financial update.IDXG) today announced financial results for the fiscal quarter ended March 31, 2021 and providedIDXG Earnings Date and Information. Interpace Biosciences last issued its earnings results on November 8th, 2023. The business services provider reported ($0.12) EPS for the quarter. The business had revenue of $9.08 million for the quarter.Jack E. Stover. Employees: 90. MORRIS CORPORATE CENTER 1,, BUILDING C, 300 INTERPACE PARKWAY, PARSIPPANY, NJ 07054. 412-224-6100. interpace.com. • *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know. Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics ...IDXG is the ticker symbol for Interpace Biosciences Inc., a company that provides molecular diagnostics, bioinformatics, and pathology services for cancer risk evaluation. The stock price, news, history, and key data of IDXG are shown on Nasdaq, a leading platform for financial markets. Take a look at our analysis of IDXG's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.; When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team.Interpace Biosciences Inc. (NASDAQ: IDXG) stock closed at 1.05 per share at the end of the most recent trading day (a -7.89 % change compared to the prior day closing price) with a volume of 3.52K shares and market capitalization of 4.54M. Is a component of indices and it is traded on NASDAQ exchange.Oct 17, 2023 · IDXG Interpace Biosciences Inc Amended Statement of Beneficial Ownership (sc 13d/a) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities ...
home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. March, 31 2021 05:20 PM | GlobeNewswire | More on IDXG. IDXG; IDXG Quote; IDXG Short; IDXG News; IDXG Articles; IDXG Message Board; 2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net …Here are the reasons to buy IDXG stock: IDXG stock price ($1.77) is close to the 52-week low ($1.70). Perhaps now is a good time to buy? See IDXG price chart. IDXG forward P/E ratio is 3.08, which is low compared to its industry peers’ …
Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Best Dividend Stocks Best High Yield Dividend Stocks Dividend Stock Comparison Dividend Calculator Dividend Returns Comparison. ETFs. ETF Center ETF …--- - Interpace Biosciences, Inc. (NASDAQ:IDXG) major shareholder Peter Kamin bought 83,250 shares of the companys stock in a transaction that occurred on Monday, March 1st. The stock was bought at an average price of $3.12 per share, with a total value of $259,740.00. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator Dividend Stocks Dividend News Dividend Calendar. ETFs. ETF Center Compare ETFs SPY ETF.James Early IDXG stock SEC Form 4 insiders trading. James has made over 1 trades of the Interpace Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently James exercised 5,000 units of IDXG stock worth $4,750 on 29 July 2020.5,000 units of IDXG stock worth $4,750 on 29 July 2020.Get the latest Interpace Biosciences, Inc. (IDXG) stock news and headlines to help you in your trading and investing decisions.IDXG Interpace Biosciences Inc Interpace Biosciences Announces Contract with Lab Benefits Management Firm In-Network Access for More Than 3 Million Members Parsippany, NJ, April 27, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences (NASDAQ: IDXG) announced today that its subsidiary, Interpace Diagnostic...EPS is the net income, or profit, a company generates during a period for each share of common stock it has outstanding. Zacks News for IDXG TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue ...
Ticker: IDXG CIK: 1054102 Form Type: 10-K Annual Report Accession Number: 0001493152-23-009106 Submitted to the SEC: Mon Mar 27 2023 4:38:59 PM EST Accepted by the SEC: Mon Mar 27 2023 Period: Saturday, December 31, 2022 Industry: Surgical And Medical Instruments And Apparatus External Resources: Stock Quote Social Media SEC.gov Bookmark the ...
Interpace Biosciences Inc (IDXG) Stock Price & News - Google Finance Home IDXG • OTCMKTS Interpace Biosciences Inc Follow Share $0.90 Oct 18, 2:52:04 PM GMT-4 · USD · OTCMKTS · Disclaimer...
Aug 31, 2022 · Interpace Biosciences on Wednesday said it had closed the sale of its pharma services business to Flagship Biosciences.IDXG CEO Thomas Burnell said with the completion of the deal, the company's ... Track Interpace Biosciences Inc (IDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Interpace Diagnostics Announces New Partnership with Israeli Specialty Services Provider PR Newswire PARSIPPANY, N.J., Jan. 20, 2017 PARSIPPANY, N.J. , Jan. 20,Find the latest Accelerate Diagnostics, Inc. (AXDX) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest iBX Group, Inc. (IBXG) stock quote, history, news and other vital information to help you with your stock trading and investing. In-Network Access for More Than 3 Million Members. Parsippany, NJ, March 10, 2020 (GLOBE NEWSWIRE) -- Interpace Diagnostics, a subsidiary of Interpace Biosciences (NASDAQ: IDXG) announced today that it has entered into a contract with Blue Cross Blue Shield of Massachusetts with over 3 million members in Massachusetts and across New …EPS forecast (this quarter) $0.11. Annual revenue (last year) $31.8M. Annual profit (last year) -$22.0M. Net profit margin. -18.42%.IDXG Stock Message Board for Investors. Interpace Diagnostics Group, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 33Bringing Insights to Life. Interpace Biosciences® (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.Take a look at our analysis of IDXG's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.; When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team.Here are the reasons to buy IDXG stock: IDXG stock price ($1.77) is close to the 52-week low ($1.70). Perhaps now is a good time to buy? See IDXG price chart. IDXG forward P/E ratio is 3.08, which is low compared to its industry peers’ …
The Company announces the complete sale of the pharma services business which could impact the IDXG Stock . For more information regarding the Company's business, visit OTC Wiki. Interpace Biosciences Inc is a leading company that specializes in enabling personalized medicinal products. This Company has closed a definitive asset …IDXG is important to the diagnostics industry. The company has been transformed. Seeking Alpha - Go to Homepage. Trending. My Portfolio. My Authors. Top Stocks. Latest News. Markets. Stock Ideas.When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...Instagram:https://instagram. buy otc stocks onlineoregon loansaffordable dental insurance njmanage portfolio Interpace Biosciences Inc. 1.05. Delayed Data. As of Nov 21. -0.09 / -7.89%. Today’s Change. 0.51. Today ||| 52-Week Range. 3.54. best financial advisors coloradowhere to buy verano stock Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021. futures trading plan Interpace Diag Group stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended ...EPS forecast (this quarter) $0.11. Annual revenue (last year) $31.8M. Annual profit (last year) -$22.0M. Net profit margin. -18.42%.